{"nct_id":"NCT02998047","title":"A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma","status":"TERMINATED","status_verified_date":"2022-02","start_date":"2016-12","start_date_type":null,"primary_completion_date":"2020-05","primary_completion_date_type":"ACTUAL","completion_date":"2020-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ATNM"]}